Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa-Reference-Cited by-同舟云学术

Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa

Published:1991 Issue:5 Volume:41 Page:453-458
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Deleu D.,Ebinger G.,Michotte Y.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00626368.pdf

Reference27 articles.

1. Mouradian M, Chase TN (1988) Central mechanisms and levodopa response fluctuations in Parkinson's disease. Clin Neuropharmacol 11: 378?385

2. Nutt JG (1987) On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics. Ann Neurol 22: 535?540

3. Nutt JG, Fellman JH (1984) Pharmacokinetics of levodopa. Clin Neuropharmacol 7: 35?49

4. Nutt JG, Woodward WR, Hamerstad JP, Carter JH, Anderson JL (1984) The ?on-off? phenomenon in Parkinson's disease: relation to levodopa absorption and transport. N Engl J Med 310: 483?484

5. Sage JI, Shuh L, Heikkila RE, Duvoisin RC (1988) Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease. Clin Neuropharmacol 11: 36?44

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Profound Impact of Gastrointestinal Stasis on Levodopa Response in Parkinson's Disease;Movement Disorders Clinical Practice;2022-02-25

2. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review;European Journal of Pharmaceutical Sciences;2020-04

3. Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption;Drug Discovery Today;2019-02

4. Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?;eNeurologicalSci;2017-09

5. Low Serum Vitamin D Levels May Contribute to Gastric Dysmotility in de novo Parkinson's Disease;Neurodegenerative Diseases;2016